Daesang Holdings Co., Ltd. Overview
Daesang Holdings is the controlling holding company of one of South Korea's oldest integrated food and fermentation groups. Its value is concentrated in a ~38–39% stake in Daesang Corporation. Daesang Corp owns the Chung Jung One condiment brand and Jongga, Korea's No. 1 kimchi brand by Nielsen Korea volume and value data for 2007–2025. It is also a large B2B supplier of starch, starch sugars, lysine, MSG and specialty amino acids. Beyond Daesang Corp, the holding company directly owns meat-distribution assets (Hyesung Provision, Crystal Farms, Hongwoo), a mid-sized builder (Daesang E&C), an IT services arm, and health-nutrition businesses (Daesang Wellife, Daesang Life Science). Consolidated revenue reached KRW 5.63T in FY2025. Group value is now shaped by three forces: growth in kimchi and K-food exports, a record cartel penalty in the domestic starch-sugar market, and an unresolved third-generation succession between the founder's granddaughters. The shares trade at roughly 0.44x book with a ~3.8–3.9% yield. That is a classic Korean holding-company discount, made deeper by the FY2025 loss.
What the company does. Daesang Holdings is a pure holding company. Its own revenue (KRW 38.06B standalone in FY2025) comes from dividends, brand/royalty fees and management fees from subsidiaries. Its consolidated results are dominated by Daesang Corp, a comprehensive food and food-ingredients manufacturer. Daesang Corp's consolidated revenue was KRW 4,401.3B in FY2025, or about 78% of the holding company's KRW 5,628.8B (derived).
Company self-description (paraphrased from public profiles derived from filings). Daesang Holdings describes itself as a food holding company. Through subsidiaries it operates a full food business: condiments, seasonings, fresh foods and frozen foods, plus materials such as starches, sweeteners and amino acids. Daesang Corp describes itself as making seasonings and food additives sold in Korea, Asia, the US, Europe, Oceania and Africa. It reports two segments, Food and Material, and also has trade and real-estate activities. It exports bio-ingredient products to about 80 countries under the Miwon brand.
Revenue model. Almost entirely product sales, split into:
-
Branded consumer packaged goods: sauces, jang (fermented pastes), kimchi, seaweed (gim), home meal replacement (HMR), processed meats.
-
B2B food service and ingredient sales to food manufacturers, beverage and liquor makers, paper mills and steelmakers.
-
Bio/fermentation commodities and specialties: lysine, MSG, histidine and other amino acids.
-
Meat wholesale distribution.
-
Construction contracting.
-
IT services.
There is no material subscription or licensing revenue at the consolidated level. Intra-group brand and management fees are eliminated on consolidation.
Value-chain position.
-
In materials, Daesang is a midstream processor. It buys corn, raw sugar and fermentation feedstocks and converts them into starch, glucose/fructose syrups, oligosaccharides, lysine and seasonings.
-
In consumer foods, it is a branded manufacturer selling through grocery, convenience, online, export and local-production channels. It runs US kimchi production in the Los Angeles area and through Lucky Foods.
-
In meat, it acts as an importer and wholesaler, and since 2024 a Hanwoo (Korean beef) processor via Hongwoo.
Customer types and end-markets.
-
Korean households (Chung Jung One, Jongga, O'food, Jibeuro ON online).
-
Global retail: Jongga is sold in more than 90 countries. The US is the largest export market.
-
B2B buyers of starch and starch sugars: confectionery, bakery, noodles, beverages, ice cream, beer, paper and steel (KFTC case record).
-
Animal-feed producers (lysine).
-
Hospitals and seniors (Daesang Wellife's medical-nutrition products).
-
Construction clients.
Independent characterisation. Economically, Daesang Holdings is a leveraged proxy on Daesang Corp, plus a portfolio of small adjacent businesses that the owner family uses for strategic and succession purposes. Daesang Corp itself has two very different halves. The branded and fermented-food half has strong brand franchises and growing export optionality. The commodity-ingredient half has thin margins and is cyclical with corn prices, amino-acid spreads and trade-remedy actions. The KFTC's 2026 ruling showed this half was operating inside a long-running price cartel. The holding company's own value-creation levers are its capital-allocation decisions in meat distribution and nutrition.
Strategy
Stated strategy themes (paraphrased from Daesang Corp's January and August 2026 releases):
-
Portfolio pruning: Exit non-core and low-efficiency categories; concentrate people and capital on core and growth categories.
-
Global K-food focus: Concentrate on kimchi, gochujang and gim. Strengthen B2B and localisation in the US, China and Japan. Enter Russia, Canada, the Middle East and Latin America. Expand K-food sauces and convenience food.
-
Materials upgrade: Expand natural seasoning materials and allulose. Strengthen high-end amino acids. Add specialty items. Diversify lysine supply regions. Broaden the alternative-sweetener portfolio.
-
Domestic food margin: Higher-value products; new targets in broth and menu seasonings; a health-oriented portfolio; manufacturing-cost improvements and efficiency.
-
Decarbonisation and energy: Decarbonise manufacturing bases and improve energy competitiveness (2H26 plan).
-
Supply chain: Build a "strategic supply chain" for cost reduction (2H25 plan).
Initiatives in the last 24 months:
Medium-term financial targets: No formal numeric guidance from Daesang Holdings or Daesang Corp was found. In 2023, Daesang set a medium-to-long-term goal of KRW 1T in annual kimchi revenue (domestic plus overseas), centred on the US (CEO Score Daily, September 2023). The target date was NV.
Cost programmes with quantified targets: ND.
Products & Services
Launch years and pricing are generally ND; consumer packaged foods are sold at retail list prices.
Food & Materials (Daesang Corp)
| Brand / line | Description | Target customer | Notes |
|---|---|---|---|
| Chung Jung One (청정원) | Master condiment brand: gochujang, doenjang, soy sauce, marinades, fish sauce, sauces, oligosaccharide syrups, HMR | Korean households | Renewed 2014 |
| Jongga (종가) | Kimchi (napa cabbage, radish, white, vegan, cucumber, "Silbi" extra-spicy, Mat Kimchi, Ilpum premium, mildly fermented for Japan) | Korea and 90+ export markets | No. 1 kimchi brand in Korea (Nielsen 2007–2025). Exports US$90M in 2025, up from ~US$32M in 2017. 1H26 exports ~US$48M, 56% of Korea's ~US$86M kimchi exports |
| Jongga US range | Original, Vegan, White, Silbi and Cucumber kimchi made in California with US-sourced cabbage, radish and green onion | US mainstream retail | Plant opened early 2022, 2,000 t/yr capacity |
| O'food | Global food brand: gochujang, sauces, seaweed snacks, HMR | International retail | Shown at SMTS 2026 (Japan) and THAIFEX-Anuga Asia 2026 |
| Mamasuka | Indonesian local brand, including Gochujang Paste (selected for THAIFEX "New to Market Street") | Indonesian consumers | Halal-certified production highlighted |
| Jibeuro ON (집으로ON) | Online-exclusive brand | Korean e-commerce shoppers | Launched 2017 |
| Seaweed (gim), sauces, convenience food | Named by Daesang as core global categories | Export and local markets | 2026 strategy |
| Broth and "menu seasoning" lines | New 2H26 B2B/B2C target categories | Food service, households | 2Q26 release |
| Miwon (MSG and seasonings) | Flagship seasoning and bio-ingredient export brand | Korea; ~80 export countries | Historic core brand |
| Starch and starch sugars | Starch, glucose, fructose syrups, starch syrup, oligosaccharides, dextrins | Confectionery, bakery, noodles, beverages, ice cream, beer, paper, steel | Gunsan complex. Subject of 2026 KFTC price re-determination order |
| Alternative sweeteners (allulose etc.) | Low-calorie rare sugars | Food and beverage makers | Named core growth business for 2026 |
| Natural seasoning materials | Clean-label flavour bases | Food manufacturers | Named core growth business for 2026 |
| Lysine | Feed-grade amino acid | Feed producers | Supply-region diversification planned for 2H26 |
| Specialty / high-end amino acids (histidine and others) | High-value fermentation products | Feed, pharma, nutrition | Cited as FY2025 growth driver |
| Processed meats (Daesang Delihaim) | Ham, sausages, luncheon meat | Households | Spun off 2021 |
Health & Nutrition
| Entity / brand | Description | Target |
|---|---|---|
| Daesang Wellife — Newcare (뉴케어) | Balanced nutrition and medical-nutrition drinks and powders. Holds 31 B2G contracts and 12 patents (TheVC) | Patients, seniors, hospitals |
| Daesang Life Science | Health functional foods. 1Q20 revenue up 45.5% YoY (Research Aleum, 2020) | Consumers |
Livestock Distribution
| Entity | Description |
|---|---|
| Hyesung Provision | Imported-meat wholesale; acquired 2021 for KRW 38.5B |
| Crystal Farms | Meat distribution; acquired 2021 for KRW 49.0B |
| Hongwoo | Hanwoo processing and distribution (80%; founded July 2021; ~25 staff; 3 patents) |
| DS&N (via Daesang Corp) | Meat wholesale |
Construction and IT
| Entity | Description |
|---|---|
| Daesang E&C | General contractor; residential brand "Wellaum." Ranked 84th in Korea's 2021 construction capability ranking |
| Daesang Information Technology | IT services for food and distribution; national R&D projects in product data and data-quality management (2020) |
Financial Narrative
Daesang Holdings — consolidated income statement
Revenue CAGR FY2021–FY2025 (derived): about 7.6%. Most of this is the FY2022 step-up, when Daesang Corp revenue rose 17.7% on grain-cost pass-through and post-pandemic recovery.
EBITDA (holding company): ND. As a proxy, Daesang Corp EBITDA (operating income plus D&A) is in table 6.4.
Commentary. Revenue has compounded steadily, while operating margin has stayed in a narrow 2–4% band typical of Korean diversified food and ingredient groups.
FY2023 trough (2.2%): The materials downturn (lysine oversupply, high corn costs) cut profits.
FY2024 recovery (3.4%): Grain input costs fell and Daesang Corp's operating income rose 43%.
FY2025 (3.5%): Operating profit rose again even though Daesang Corp's own operating income fell. That implies better contributions from non-Daesang Corp subsidiaries (meat, construction, nutrition), although segment data to confirm this is ND.
The FY2025 net loss: is non-operating. It reflects a provision recognised at Daesang Corp for the KFTC starch cartel penalty. The provision was booked as an "other expense" and later moved to accrued liabilities (KRW 234.1B) in 1H26 (BusinessPost).
Daesang Holdings — quarterly run-rate
YoY changes: 2Q25 revenue +5.8%, operating income +9.3%; 3Q25 revenue +6.8%, operating income +17.9%; 1Q26 revenue +1.2%, operating income +48.1%, net income +153.9%; 2Q26 revenue +8.4%, operating income +19.2%, net income +13.8% (ETF Shopping from DART; Google Finance for revenue and R&D).
Commentary. 1H26 consolidated operating income was about KRW 137.5B (derived), up roughly 30% YoY. Profitability in 2026 is clearly recovering at the operating level.
Daesang Holdings — balance sheet and cash flow
Implied book equity: about KRW 650B attributable (derived from a market cap of ~KRW 286B at 0.44x P/B). Treat as indicative only.
Commentary: The sharp fall in consolidated cash from KRW 674.4B to KRW 300.5B in 1H26 matches Daesang Corp's pre-emptive debt repayment and investment outflow of more than KRW 400B in 2Q26, made before paying the KRW 234.1B KFTC fine (Nate, 24 August 2026). The FY2022 negative operating cash flow came from working-capital build during the grain-price spike (Daesang Corp operating cash flow was -KRW 90.9B).
Daesang Corporation (001680) — the operating engine
Source: StockAnalysis (S&P Global data). FY2021 net income includes a KRW 76.9B gain on asset sales; the nature of the asset was NV.
Ratios — Daesang Holdings
Trend synthesis. Over five years the group has grown revenue at a high single-digit rate. Operating margins are thin but stable, and capital intensity is rising (Daesang Corp D&A up 51% from FY2021 to FY2025). The FY2025 cartel penalty is the defining inflection. It erased about two years of attributable earnings, depleted Daesang Corp's liquidity, and will force a choice in FY2026–FY2027 between deleveraging, maintaining dividends, and funding overseas growth capex.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship to Daesang Holdings | Business |
|---|---|---|
Daesang Corporation (KOSPI 001680) | Subsidiary. Holding company stake 39.28% (CEO Score, 2024) and 38.03% (FY2025 business report as summarised by ETF Shopping). Holding co. plus affiliates hold 43.7% (Hanwha, Feb 2025) | Food and materials |
Daesang Life Science | 100% (Asia Economy, 2020) | Health functional foods |
Daesang Wellife | Group affiliate (founded October 2017; ~326 staff) | Medical / senior nutrition ("Newcare") |
Hyesung Provision | Holding company subsidiary | Meat import and wholesale |
Hongwoo | 80% via Hyesung Provision (2024) | Hanwoo processing and distribution |
Crystal Farms | Holding company subsidiary (acquired 2021) | Meat distribution |
Daesang E&C (ex-Dongseo Construction) | Holding company / Dongseo Industry (100% since 2008) | Construction ("Wellaum" brand) |
Daesang Information Technology | Holding company subsidiary | IT services |
Daesang Delihaim | Daesang Corp (spun off 2021) | Processed meats |
DS&N | Daesang Corp (acquired 2019) | Meat wholesale |
PT Daesang Indonesia (and other overseas subsidiaries) | Daesang Corp | Starch/sugar and foods (Mamasuka brand) |
Daesang America / Lucky Foods | Daesang Corp | US kimchi production |
Daesang Japan Inc.; Daesang Foods Japan Inc. (2023) | Daesang Corp | Japan sales |
Daesang (Lianyungang), China | Daesang Corp (shown in 2020 IR deck) | China operations |
Daesang Pet Life | Affiliate since 2023 | Pet food |
Segment Overview
| Segment | 2Q26 share (%) | Derived 2Q26 revenue (KRW Bn, approx.) |
|---|---|---|
Food and materials | 84 | 1,260 |
Livestock distribution | 10 | 150 |
Construction | 4 | 60 |
Information technology | 1 | 15 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn; FY21–FY23 rounded to source precision) | 4,200 | 5,200 | 5,300 | 5,356 | 5,629 |
Gross profit (KRW Bn, rounded to source precision) | 1,100 | 1,200 | 1,300 | 1,400 | 1,500 |
Operating income (KRW Bn, Butler) | 163.0 | 143.8 | 114.6 | 184.0 | 199.8 |
Net income incl. minorities (KRW Bn, Butler) | 142.7 | 78.1 | 65.5 | 79.9 | -293.2 |
Net income attributable to parent (KRW Bn, Paasa) | 53.9 | 32.2 | 21.1 | 20.4 | -106.9 |
EPS basic (KRW, Paasa) | 1,450 | 868 | 568.1 | 548 | -2,878.45 |
DPS common (KRW, by fiscal year) | — | — | 270 | 270 | 300 |
DPS preferred (KRW, by fiscal year) | — | — | 280 | 280 | 310 |
Operating margin (%, derived) | 3.9 | 2.8 | 2.2 | 3.4 | 3.5 |
Net margin incl. minorities (%, derived) | 3.4 | 1.5 | 1.2 | 1.5 | -5.2 |
Financial Analysis
| Metric | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 1,380 | 1,490 | 1,350 | 1,430 | 1,500 |
Operating income (KRW Bn) | 49.9 | 69.3 | — | 78.1 | 59.4 |
Net income (KRW Bn) | 22.7 | 35.3 | — | 45.4 | 25.8 |
R&D expense (KRW Bn) | 17.91 | 17.74 | 19.19 | 16.39 | — |
Key Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | 1H26 |
|---|---|---|---|---|---|
Current assets (KRW Bn, Valueline) | 2,099.8 | 2,137.1 | 2,191.9 | 2,188.4 | 2,012.4 |
Cash and equivalents (KRW Bn, Valueline) | 630.0 | 806.6 | 749.8 | 674.4 | 300.5 |
Short-term financial assets (KRW Bn) | 66.5 | 38.6 | 65.6 | 91.1 | 79.6 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (KRW Bn, Paasa) | 23.3 | -132.9 | 322.4 | 178.3 | 242.9 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 3,470.0 | 4,084.1 | 4,107.5 | 4,255.1 | 4,401.3 |
Revenue growth (%) | 11.5 | 17.7 | 0.6 | 3.6 | 3.4 |
Gross profit (KRW Bn) | 878.0 | 964.2 | 1,012.9 | 1,135.7 | 1,172.5 |
SG&A (KRW Bn) | 651.2 | 734.2 | 784.4 | 840.6 | 861.7 |
R&D (KRW Bn) | 27.7 | 34.7 | 41.2 | 46.5 | 57.0 |
Operating income (KRW Bn) | 149.0 | 143.0 | 123.6 | 176.8 | 164.6 |
D&A (KRW Bn) | 110.2 | 127.4 | 136.9 | 146.8 | 165.9 |
EBITDA (KRW Bn, derived = OI + D&A) | 259.2 | 270.4 | 260.5 | 323.6 | 330.5 |
Other non-operating income/expense (KRW Bn) | -21.6 | -3.0 | -3.7 | -9.9 | -380.7 |
Net income (KRW Bn) | 144.1 | 83.1 | 67.1 | 95.2 | -304.2 |
Net income to common (KRW Bn) | 144.1 | 83.1 | 67.1 | 95.2 | -292.7 |
Operating cash flow (KRW Bn) | 58.7 | -90.9 | 374.8 | 187.7 | 188.1 |
Gross margin (%, derived) | 25.3 | 23.6 | 24.7 | 26.7 | 26.6 |
Operating margin (%) | 4.29 | 3.50 | 3.01 | 4.16 | 3.74 |
EBITDA margin (%, derived) | 7.5 | 6.6 | 6.3 | 7.6 | 7.5 |
Net margin (%) | 4.15 | 2.03 | 1.63 | 2.24 | -6.65 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansValuation Snapshot
| Metric | Value | Basis / source |
|---|---|---|
Total debt | KRW 1,370B | 31 December 2024; Simply Wall St |
Cash | KRW 705.0B | 31 December 2024 |
Net debt | KRW 664.6B | 31 December 2024 |
Net debt / EBITDA | 2.1x | FY2024; Simply Wall St |
EBIT interest cover | 4.8x | FY2024; Simply Wall St |
Net debt (Hanwha) | KRW 650B (FY2023), KRW 651B (FY2024P) | Hanwha, February 2025 |
ROE (Hanwha) | 5.1% (FY2023), 6.7% (FY2024P) | Hanwha, February 2025 |
Cash at end-2Q26 | KRW 42.6B | After debt repayment; fine not yet paid (Nate, August 2026) |
2Q26 results | Revenue KRW 1,165.8B (+8.3%), OI KRW 46.5B (+16.2%), NI KRW 19.6B (+7.6%) | Dealsite, 14 August 2026 |
1H26 results | Revenue KRW 2,275.6B (+3.1%), OI KRW 103.5B (+6.9%) | Dealsite |
Share price | KRW 7,650–7,920 | StockHub / Valueline, 7–15 October 2026 |
52-week range | KRW 6,470 – 11,060 | StockHub |
Performance: 1 month / 6 months / YTD / 1 year / 5 years (%) | -1.76 / -17.72 / -20.41 / -13.53 / -22.39 | Paasa (snapshot date NV, likely mid-2026) |
Market cap | KRW 277–286B | October 2026 |
P/E (TTM) | Negative (-3.6x) | Valueline |
P/B | 0.44–0.45x | Valueline / StockHub |
Dividend yield | ~3.8–3.9% | StockHub / Butler |
Preferred share (084695) | KRW 11,260–11,860 (August 2026); market cap ~KRW 11.9B; yield ~2.6% | ETF Shopping / StockHub |
Analyst coverage | No sell-side estimates (Simply Wall St: 0 analysts) | — |
Financial Analysis — ROE
| Ratio | Value | Source / note |
|---|---|---|
ROE (TTM) | -12.21% (Valueline, October 2026); -17.45% (StockHub) | Negative because of the FY2025 provision |
P/B | 0.44–0.45x | Valueline / StockHub |
P/E (TTM) | Negative (-3.6x) | Valueline |
Revenue by Region
| Indicator | 2017 | 2025 | 1H26 |
|---|---|---|---|
Jongga kimchi exports (USD Mn) | 32 | 90 | 48 |
Indicator | 1Q25 | 2Q25 | — |
Korean lysine export value (USD Mn, Korea Customs via Hana) | 58.0 | 28.6 | — |
Capital Markets
| Item | Value |
|---|---|
Daesang Corp shares outstanding | 34.648M |
Daesang Corp price (27 July 2026) | KRW 17,890 |
Daesang Corp market cap (derived) | ~KRW 620B |
Holdings stake (FY2025 report) | 38.03% |
Look-through value of the stake (derived) | ~KRW 236B |
Holdings market cap (October 2026) | ~KRW 280B |
Per-Share Data
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
DPS common (KRW) | 270 | 270 | 300 |
DPS preferred (KRW) | 280 | 280 | 310 |
Analyst Conclusions
Management guidance. No numeric guidance. Daesang Corp's stated priorities for 2H26 are:
-
higher-value products (broth, menu seasonings, health portfolio);
-
kimchi, gim, sauce and convenience-food localisation and new countries;
-
specialty materials, lysine supply diversification, alternative sweeteners;
-
decarbonisation.
Consensus (Daesang Corp only; older and pre-fine):
Simply Wall St cites ~4.0% annual revenue growth forecast for Daesang over three years. No consensus exists for Daesang Holdings. 1H26 actual operating income of KRW 103.5B annualises to about KRW 207B, below those earlier estimates.
Bull case
-
Operating earnings re-rate: Holdings operating income rose ~30% YoY in 1H26 and the fine is already expensed. FY2026 attributable EPS should swing sharply positive from -KRW 2,878, leaving the stock at a low P/E on normalised earnings and 0.44x book.
-
Kimchi as a global category: Jongga's exports nearly tripled from 2017 to 2025 to US$90M, and it holds 56% of Korean kimchi exports with local US production. That gives the group a scarce, defensible growth franchise.
-
Value-up and succession catalysts: Korea's governance reforms, a possible formal succession resolution, or simplification of non-core holdings could narrow a discount that values everything outside Daesang Corp at about KRW 45B.
Bear case
-
Regulatory overhang is not over: Two further KFTC cases are pending, along with criminal proceedings and likely customer damages suits. The sector-wide starch-sugar exposure could approach KRW 1.2T (Digital Times), and Daesang is the market leader.
-
Balance-sheet strain: With cash of KRW 42.6B at end-2Q26 and a KRW 234.1B payment due, Daesang Corp must borrow. That raises interest costs and could pressure ratings and dividends.
-
Structurally thin margins: The price re-determination order limits B2B pricing for three years, and domestic food demand is soft. Group operating margin may stay stuck near 3–4%, below peers.
Key catalysts and monitorables (next 12 months)
-
Payment and financing of the KRW 234.1B fine (new debt vs. cash), and any appeal.
-
KFTC decisions on the bid-rigging and by-product cases; criminal trial milestones.
-
3Q26 results (expected around 14 November 2026) and FY2026 results (around March 2027).
-
2026 domestic credit-rating reviews of Daesang Corp.
-
FY2026 dividend decision (record date around March 2027).
-
Jongga US volume growth and new-market entries (Japan, Canada, Middle East).
-
Lysine pricing and the durability of the EU trade-remedy benefit; corn prices.
-
Any succession-related share transactions between the Lim sisters, or group restructuring.
-
KCGS ESG grade adjustments after the cartel ruling.
Analyst verdict. Daesang Holdings is a deep-value, high-friction security. Its operating engine is healthier than its reported numbers suggest. Daesang Corp has grown revenue for five straight years, kept EBITDA above KRW 320B in FY2024–FY2025, and returned to double-digit operating-profit growth in 2Q26. It also owns, in Jongga, one of very few Korean food brands with clear category leadership both at home and abroad.
Against this, the 2026 KFTC ruling is more than a one-off charge. It shows that part of the materials franchise's profitability was supported by collusion. The remedy constrains pricing for three years, and two further cases and a criminal trial remain open. The fine has also turned Daesang Corp's balance sheet from comfortable to tight just as the group is funding overseas capacity. At the holding level, a family-controlled structure with an unresolved sister succession means minority shareholders own about 27% of an entity whose capital-allocation decisions (meat distribution, construction) have not clearly been value-accretive.
The valuation already discounts much of this. At about 0.44x book and roughly KRW 280B of market value, against a look-through Daesang Corp stake worth about KRW 236B, investors pay little for the rest of the portfolio. They are effectively being paid a ~3.9% yield to wait.
Our assessment is a cautious "value with catalysts required" stance. Upside depends on three things: (i) clean resolution or reasonable sizing of the remaining KFTC matters; (ii) financing of the fine without a dividend cut or rating downgrade; and (iii) visible progress in governance, such as treasury-share policy, clearer segment disclosure, or succession clarity. Until then, the holding discount is likely to persist, and Daesang Corp itself is the cleaner way to play the kimchi and K-food growth story.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Background (public) | Tenure notes |
|---|---|---|---|
Lim Chang-wook (임창욱) | Honorary Chairman; Representative Director, Daesang Holdings | Son of founder Lim Dae-hong | Long-serving group head; co-CEO of the holding company. Held ~3.62% of Holdings after open-market purchases in November 2018 |
Choi Sung-soo (최성수) | Representative Director, Daesang Holdings | Professional manager | Co-CEO; prior roles NV |
Park Hyun-joo (박현주) | Vice Chairman, Daesang Holdings (registered director per 2021–2022 reports) | Wife of Lim Chang-wook | Current status NV |
Lim Se-ryung (임세령) | Vice Chairman; strategy head (전략담당중역), Daesang Holdings; registered director | Business administration, Yonsei University; psychology, NYU. Joined 2012; led marketing from 2016; led 2014 Chung Jung One renewal and 2017 Jibeuro ON launch; drove the meat-distribution M&A | Promoted vice chairman in 2021. Holds 20.41% of Holdings |
Lim Sang-min (임상민) | Vice President (부사장) | Joined Daesang 2009; strategy and planning roles across Food and Material business units | Largest individual shareholder of Holdings (36.71%) |
Lim Jung-bae (임정배) | CEO, Daesang Corporation | Professional manager | Fronted 2026 SMTS and THAIFEX campaigns |
Oh Yeon-taek (오연택) | CEO, Kimchi CIC, Daesang Corporation | Leads the global kimchi business | Quoted in September 2026 US expansion release |
Major Shareholders
| Holder (Daesang Holdings common) | Stake (%) | Date / source |
|---|---|---|
Lim Sang-min | 36.71 | CEO Score 2024; Dealsite July 2026 |
Lim Se-ryung | 20.41 | Same |
Lim Chang-wook | ~3.62 | November 2018 (Dealsite); current NV |
Minority shareholders (19,362 holders) | 26.73 | FY2025 business report (ETF Shopping) |
National Pension Service | Holder (TheVC, July 2026); % ND | — |
Competitive Landscape
Competitors by Segment
| Business | Competitors |
|---|---|
Branded condiments / jang | CJ CheilJedang (Haechandle), Sempio, Ottogi, Pulmuone, Sajo |
Kimchi | CJ CheilJedang (Bibigo), Pulmuone, local producers; in the US, local and Korean-American brands |
HMR / convenience / seaweed | CJ CheilJedang, Ottogi, Dongwon F&B, Pulmuone, Nongshim |
Starch and starch sugars (Korea B2B) | Samyang Corp, Sajo CPK, CJ CheilJedang. The four firms including Daesang hold 95.7% of starch and 86.4% of starch sugar (KFTC) |
Lysine / feed amino acids | CJ CheilJedang Bio, Chinese producers (subject to EU duties), ADM, others |
MSG / seasonings (global) | Ajinomoto, CJ CheilJedang, Chinese producers |
Medical / senior nutrition | Maeil (Selex) and others (NV) |
Meat distribution | Fragmented importers and wholesalers |
Peer Comparison FY2025
| Company | Revenue (KRW Bn) | Revenue growth (%) | Operating income (KRW Bn) | Operating margin (%) | R&D intensity (%) |
|---|---|---|---|---|---|
Daesang Holdings (consolidated) | 5,628.8 | 5.1 | 199.8 | 3.5 | ~1.3 (derived run-rate) |
Daesang Corporation | 4,401.3 | 3.4 | 164.6 | 3.7 | 1.29 |
CJ CheilJedang (consolidated incl. CJ Logistics) | 27,342.6 | 0.4 | 1,233.6 | 4.5 | — |
CJ CheilJedang (excl. CJ Logistics) | 17,754.9 | -0.6 | 861.2 | 4.9 | — |
Ottogi | 3,674.5 | 3.8 | 177.3 | 4.8 | — |
Competitor Detail
| Firm | Fine (KRW Bn) |
|---|---|
Daesang | 234.1 |
Samyang Corp | 210.3 |
Sajo CPK | 200.1 |
CJ CheilJedang | 103.0 |



